Historical Perspective and Current Trends in Anticancer Drug Development

Cancers Pub Date : 2024-05-15 DOI:10.3390/cancers16101878
Katarzyna Gach-Janczak, Joanna Drogosz-Stachowicz, Anna Janecka, Karol Wtorek, Marek Mirowski
{"title":"Historical Perspective and Current Trends in Anticancer Drug Development","authors":"Katarzyna Gach-Janczak, Joanna Drogosz-Stachowicz, Anna Janecka, Karol Wtorek, Marek Mirowski","doi":"10.3390/cancers16101878","DOIUrl":null,"url":null,"abstract":"Cancer is considered one of the leading causes of death in the 21st century. The intensive search for new anticancer drugs has been actively pursued by chemists and pharmacologists for decades, focusing either on the isolation of compounds with cytotoxic properties from plants or on screening thousands of synthetic molecules. Compounds that could potentially become candidates for new anticancer drugs must have the ability to inhibit proliferation and/or induce apoptosis in cancer cells without causing too much damage to normal cells. Some anticancer compounds were discovered by accident, others as a result of long-term research. In this review, we have presented a brief history of the development of the most important groups of anticancer drugs, pointing to the fact that they all have many side effects.","PeriodicalId":504676,"journal":{"name":"Cancers","volume":"47 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/cancers16101878","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer is considered one of the leading causes of death in the 21st century. The intensive search for new anticancer drugs has been actively pursued by chemists and pharmacologists for decades, focusing either on the isolation of compounds with cytotoxic properties from plants or on screening thousands of synthetic molecules. Compounds that could potentially become candidates for new anticancer drugs must have the ability to inhibit proliferation and/or induce apoptosis in cancer cells without causing too much damage to normal cells. Some anticancer compounds were discovered by accident, others as a result of long-term research. In this review, we have presented a brief history of the development of the most important groups of anticancer drugs, pointing to the fact that they all have many side effects.
抗癌药物开发的历史展望和当前趋势
癌症被认为是 21 世纪的主要死亡原因之一。数十年来,化学家和药理学家一直在积极寻找新的抗癌药物,重点是从植物中分离出具有细胞毒性的化合物,或筛选成千上万的合成分子。有可能成为新型抗癌药物候选物质的化合物必须具有抑制癌细胞增殖和/或诱导癌细胞凋亡的能力,同时又不会对正常细胞造成太大损害。有些抗癌化合物是偶然发现的,有些则是长期研究的结果。在这篇综述中,我们简要介绍了最重要的几类抗癌药物的发展史,并指出它们都有许多副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信